Pancreatic Acinar Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Pancreatic Acinar Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation [Phase 2]
ClinicalTrials.gov update describes a Phase II randomized study (APOLLO) comparing olaparib versus placebo after curative-intent therapy in …
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: Vaccine Therapy and Sargramostim in Treating Patients With Pancreas Cancer That Cannot Be Removed By Surgery [Phase 1]
Phase 1 trial evaluating a vaccine therapy in combination with sargramostim for locally advanced pancreatic cancer that cannot be removed su…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: GDC-0449 and Erlotinib Hydrochloride With or Without Gemcitabine Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer or Solid Tumors That Cannot Be Removed by Surgery [Phase 1]
Phase 1 trial evaluating GDC-0449 (vismodegib) and erlotinib hydrochloride, with or without gemcitabine hydrochloride, in metastatic pancrea…
-
CLINICAL_TRIALS trial_result · 2026-03-11Clinical Trial Update: Olaparib in Subjects With Advanced Pancreatic Acinar Cell Carcinoma [Phase 2]
Olaparib was evaluated in a Phase 2 trial for advanced pancreatic acinar cell carcinoma, but the study was terminated and results have been …
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: The PLATINUM Trial: Optimizing Chemotherapy for the Second-Line Treatment of Metastatic BRCA1/2 or PALB2-Associated Metastatic Pancreatic Cancer [Phase 2, Phase 3]
Clinical trial update for the PLATINUM study evaluating second-line platinum-based chemotherapy for metastatic BRCA1/2- or PALB2-associated …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-10-02Clinical Trial Update: Tovorafenib (DAY101) Monotherapy for Patients With Melanoma and Other Solid Tumors [Phase 2]
Phase 2 monotherapy trial of tovorafenib (DAY101) in melanoma and other solid tumors was terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2018-02-07Clinical Trial Update: Carboplatin and Paclitaxel With or Without Viral Therapy in Treating Patients With Recurrent or Metastatic Pancreatic Cancer [Phase 2]
A Phase 2 trial evaluating carboplatin and paclitaxel with or without viral therapy in patients with recurrent or metastatic pancreatic canc…
-
CLINICAL_TRIALS trial_result · 2016-03-09Clinical Trial Update: Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With Chemotherapy [Phase 2]
Phase 2 trial update on selumetinib and MK-2206 or mFOLFOX for metastatic pancreatic cancer; the study has completed and results were posted…